[Autohome Inc. Announces the Shareholder Resolutions Adopted at 2017 Annual General Meeting and Board Change Autohome Company 2017 AGM BEIJING, December 01, 2017 (GLOBE NEWSWIRE) Autohome Inc. ( 1. re-elected Ms. Han Qiu be 2. Mr. Zheng Liu be appointed as a director of the Company and each direct]
[Dated 29 November 2017 Supplemental Deed With respect to the Equitable Mortgage Over Shares in SHANGHAIMED, INC. and GOPHER GLOBAL CREDIT FUND II This Supplemental Deed Between: (1) SHANGHAIMED, INC., Mortgagor (2) GOPHER GLOBAL CREDIT FUND II Mortgagee Whereas (A) Equitable Share Mortgage (B) (C) (]
[COMPLETION OF THE SALE BY HL GLOBAL ENTERPRISES LIMITED OF ALL ITS SHARES IN LKN INVESTMENT INTERNATIONAL PTE. LTD. Singapore, Singapore December 1, 2017 On a preliminary basis, the Company expects to record a profit after tax of RMB320.0 million and a profit attributable to equity holders of th]
[Dated 29 November 2017 Supplemental Deed With respect to the Equitable Mortgage Over Shares in SHANGHAIMED, INC. and GOPHER GLOBAL CREDIT FUND II This Supplemental Deed Between: (1) SHANGHAIMED, INC., Mortgagor (2) GOPHER GLOBAL CREDIT FUND II Mortgagee Whereas (A) Equitable Share Mortgage (B) (C) (]
[COMPLETION OF THE SALE BY HL GLOBAL ENTERPRISES LIMITED OF ALL ITS SHARES IN LKN INVESTMENT INTERNATIONAL PTE. LTD. Singapore, Singapore December 1, 2017 On a preliminary basis, the Company expects to record a profit after tax of RMB320.0 million and a profit attributable to equity holders of th]
[Sinovac Biotech Cures Nasdaq Filing Deficiency BEIJING, December 1, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that it has received a Nasdaq Staff letter indicating that the Form 20-F]
[Sinovac Biotech Cures Nasdaq Filing Deficiency BEIJING, December 1, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that it has received a Nasdaq Staff letter indicating that the Form 20-F]
